Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1866 1
1916 1
1929 1
1931 2
1939 1
1942 1
1945 3
1947 1
1948 14
1949 11
1950 8
1951 4
1952 11
1953 7
1954 5
1955 5
1956 6
1957 11
1958 17
1959 11
1960 11
1961 11
1962 36
1963 37
1964 49
1965 57
1966 38
1967 47
1968 34
1969 51
1970 78
1971 93
1972 110
1973 116
1974 116
1975 172
1976 186
1977 194
1978 195
1979 242
1980 275
1981 254
1982 253
1983 296
1984 328
1985 370
1986 419
1987 461
1988 555
1989 589
1990 581
1991 592
1992 676
1993 732
1994 792
1995 912
1996 1055
1997 1055
1998 1102
1999 1326
2000 1525
2001 1751
2002 1919
2003 2113
2004 2282
2005 2655
2006 2886
2007 3273
2008 5046
2009 5988
2010 6468
2011 6916
2012 7036
2013 6159
2014 6165
2015 6596
2016 6232
2017 6931
2018 7597
2019 8530
2020 10313
2021 8578
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

120,083 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Chunleung
Page 1
Did you mean chun sung ho (7 results)?
Heterotopic ossification.
Shehab D, Elgazzar AH, Collier BD. Shehab D, et al. J Nucl Med. 2002 Mar;43(3):346-53. J Nucl Med. 2002. PMID: 11884494 Free article. Review.
Heterotopic ossification (HO) is the presence of bone in soft tissue where bone normally does not exist. ...Before therapy begins, bone scanning may be requested to confirm the diagnosis of HO. In addition, surgical resection of HO is used to preserve joint m …
Heterotopic ossification (HO) is the presence of bone in soft tissue where bone normally does not exist. ...Before therapy begins, bo …
Heterotopic ossification: a systematic review.
Edwards DS, Clasper JC. Edwards DS, et al. J R Army Med Corps. 2015 Dec;161(4):315-21. doi: 10.1136/jramc-2014-000277. Epub 2014 Jul 11. J R Army Med Corps. 2015. PMID: 25015927 Review.
Heterotopic ossification (HO) is the formation of mature lamellar bone in extraskeletal soft tissues. ...A systematic review in PubMed and the Cochrane Database identified research articles related to HO to illustrate the military problem of HO and its manage …
Heterotopic ossification (HO) is the formation of mature lamellar bone in extraskeletal soft tissues. ...A systematic review in PubMe …
Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors.
Intagliata S, Salerno L, Ciaffaglione V, Leonardi C, Fallica AN, Carota G, Amata E, Marrazzo A, Pittalà V, Romeo G. Intagliata S, et al. Eur J Med Chem. 2019 Dec 1;183:111703. doi: 10.1016/j.ejmech.2019.111703. Epub 2019 Sep 17. Eur J Med Chem. 2019. PMID: 31550661 Review.
Among the different HO isoforms, HO-2 stands out for its neuroprotective properties and modulatory activity in male reproduction. ...To the best of our knowledge, among HO-2 inhibitors, clemizole derivatives are the most selective HO-2 inhibitors repor …
Among the different HO isoforms, HO-2 stands out for its neuroprotective properties and modulatory activity in male reproducti …
HO in pregnancy.
Bainbridge SA, Smith GN. Bainbridge SA, et al. Free Radic Biol Med. 2005 Apr 15;38(8):979-88. doi: 10.1016/j.freeradbiomed.2004.11.002. Free Radic Biol Med. 2005. PMID: 15780756 Review.
In this review the role of HO, and its catalytic products, will be examined in the context of pregnancy. The different isoforms of the HO enzyme (HO-1, HO-2, HO-3) have been localized throughout placental tissue, and have been shown to be physio …
In this review the role of HO, and its catalytic products, will be examined in the context of pregnancy. The different isoforms of th …
A focus on heme oxygenase-1 (HO-1) inhibitors.
Pittalà V, Salerno L, Romeo G, Modica MN, Siracusa MA. Pittalà V, et al. Curr Med Chem. 2013;20(30):3711-32. doi: 10.2174/0929867311320300003. Curr Med Chem. 2013. PMID: 23746277 Review.
HO exists in two distinct, catalytically active isoforms: HO-1 and HO-2. HO-1 is an inducible 32-kDa protein, while HO-2 is a constitutively synthesized 36-kDa protein and generally is unresponsive to any of the inducers of HO-1. ...
HO exists in two distinct, catalytically active isoforms: HO-1 and HO-2. HO-1 is an inducible 32-kDa protein, wh
2.1 mum composite Tm/Ho:YAG laser.
Huang H, Huang J, Ge Y, Zheng H, Weng W, Wu H, Lin W. Huang H, et al. Opt Lett. 2018 Mar 15;43(6):1271-1274. doi: 10.1364/OL.43.001271. Opt Lett. 2018. PMID: 29543269
We realize Ho laser operation in a composite Tm/Ho:YAG gain medium for the first time, to the best of our knowledge, which was integrated via diffusion bonding the Tm-doped and Ho-doped crystals into a single bulk structure. ...Such a scheme is demonstrated t …
We realize Ho laser operation in a composite Tm/Ho:YAG gain medium for the first time, to the best of our knowledge, which was …
HO-1 expression control in the rat glomerulus.
Detsika MG, Duann P, Lianos EA. Detsika MG, et al. Biochem Biophys Res Commun. 2015 May 8;460(3):786-92. doi: 10.1016/j.bbrc.2015.03.107. Epub 2015 Mar 27. Biochem Biophys Res Commun. 2015. PMID: 25824035
The present study identifies a unique HO-1 expression pattern in the renal glomerulus indicative of presence of HO-1 expression control following prolonged HO-1 induction. HO-1 and HO-2 expression in response to the natural HO substrate/i …
The present study identifies a unique HO-1 expression pattern in the renal glomerulus indicative of presence of HO-1 expressio …
Simultaneous (166)Ho/(99m)Tc dual-isotope SPECT with Monte Carlo-based downscatter correction for automatic liver dosimetry in radioembolization.
van Rooij R, Braat AJAT, de Jong HWAM, Lam MGEH. van Rooij R, et al. EJNMMI Phys. 2020 Mar 4;7(1):13. doi: 10.1186/s40658-020-0280-9. EJNMMI Phys. 2020. PMID: 32130539 Free PMC article.
Next, (99m)Tc downscatter in the 81-keV (166)Ho window was Monte Carlo simulated to allow quantitative reconstruction of the (166)Ho images. ...RESULTS: Given the same level of activity, (99m)Tc contributes twice as many counts to the 81-keV window than (166)Ho
Next, (99m)Tc downscatter in the 81-keV (166)Ho window was Monte Carlo simulated to allow quantitative reconstruction of the (166) …
HO-1/CO system in tumor growth, angiogenesis and metabolism - Targeting HO-1 as an anti-tumor therapy.
Loboda A, Jozkowicz A, Dulak J. Loboda A, et al. Vascul Pharmacol. 2015 Nov;74:11-22. doi: 10.1016/j.vph.2015.09.004. Epub 2015 Sep 25. Vascul Pharmacol. 2015. PMID: 26392237 Review.
Heme oxygenase-1 (HO-1, hmox-1) catalyzes the rate-limiting step in the heme degradation processes. ...The inhibition of HO-1 has been proposed as an anti-cancer therapy, however, because of non-specific effects of known HO-1 inhibitors, the discovery of idea …
Heme oxygenase-1 (HO-1, hmox-1) catalyzes the rate-limiting step in the heme degradation processes. ...The inhibition of HO-1 …
Synergistic Interaction Between Heme Oxygenase (HO) and Nuclear-Factor E2- Related Factor-2 (Nrf2) against Oxidative Stress in Cardiovascular Related Diseases.
Ndisang JF. Ndisang JF. Curr Pharm Des. 2017;23(10):1465-1470. doi: 10.2174/1381612823666170113153818. Curr Pharm Des. 2017. PMID: 28088909 Review.
Upon activation, Nrf2 translocates to the nucleus and binds to the antioxidant-response-element located at the promoter region of some anti-oxidants including the cytoprotective protein HO. Since the HO-1 gene harbors binding site for Nrf2, mutual stimulatory and re …
Upon activation, Nrf2 translocates to the nucleus and binds to the antioxidant-response-element located at the promoter region of some anti- …
120,083 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page